Results 171 to 180 of about 6,656,778 (331)

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Hyperuniform Active Matter

open access: yes
Abstract Hyperuniformity in driven disordered systems [1,2] and giant number fluctuations in active matter [3,4] represent opposite ends in a spectrum of statistical correlations found in physical systems outside of thermal equilibrium. Despite both these phenomena representing milestones in our understanding of non-equilibrium physics -- with ...
Alberto Fernandez-Nieves   +5 more
openaire   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, EarlyView.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

An equation of state for active matter [PDF]

open access: green, 2022
Samuel Cameron   +3 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Fabrication of microcompartments with controlled size and shape for encapsulating active matter [PDF]

open access: yesFront Cell Dev Biol
Vianay B   +6 more
europepmc   +2 more sources

No long-term benefits from resistance training on brain grey matter volumes in active older adults at retirement age [PDF]

open access: gold
Mads Bloch‐Ibenfeldt   +6 more
openalex   +1 more source

Transient Casimir Forces from Quenches in Thermal and Active Matter [PDF]

open access: bronze, 2017
Christian M. Rohwer   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy